The Stanford School of Medicine has received a five-year, $53 million grant renewal from the Clinical and Translational Science Award Program.
The CTSA Program is overseen by the National Center for Advancing Translational Sciences at the National Institutes of Health.
“This funding will help us strengthen our clinical and translational research infrastructure in a way that will prepare us for the remarkable transformation underway in precision health and population health research,” said Mark Cullen, MD, senior associate vice provost for research at Stanford and senior associate dean for research at the School of Medicine. “Ultimately, this will accelerate the application of research discoveries into clinical care, helping people live longer, healthier lives.”